Adam Lauring, MD, PhD
Professor of Internal Medicine
Professor of Microbiology and Immunology
Professor of Ecology and Evolutionary Biology
College of Literature, Science, and the Arts
[email protected]

Available to mentor
Adam Lauring, MD, PhD
Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications
    • About

    Dr. Lauring is a physician-scientist with a research interest in the genetics and evolution of RNA viruses

    Links
    • Lauring Lab
    Qualifications
    • MD
      University of Washington, Seattle, 2002
    • PhD
      University of Washington, Seattle, 2000
    • BS
      Yale University, New Haven, 1994
    Research Overview

    Dr. Lauring’s laboratory has worked in three main areas. First, they study the importance of mutation rate and mutational tolerance to the evolution of poliovirus and influenza virus. More recently, they have utilized next generation sequencing of patient samples to define the within-host evolution and transmission of influenza virus, poliovirus, and SARS-CoV-2. Since the beginning of the COVID pandemic, his laboratory has collaborated with large teams to study the genomic epidemiology of respiratory viruses and the effectiveness of vaccines against them.

    Recent Publications See All Publications
    • Journal Article
      Effectiveness of the original monovalent mRNA COVID-19 vaccination series against hospitalization for COVID-19-associated venous thromboembolism.
      Hager DN, Zhu Y, Sohn I, Stubblefield WB, Streiff MB, Gaglani M, Steingrub JS, Duggal A, Felzer JR, O'Rourke M, Peltan ID, Mohamed A, Stiller R, Wilson JG, Qadir N, Ginde AA, Zepeski AE, Mallow C, Lauring AS, Johnson NJ, Gibbs KW, Kwon JH, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network . J Infect Dis, 2024 Oct 15; DOI:10.1093/infdis/jiae502
      PMID: 39405261
    • Journal Article
      Influenza A virus within-host evolution and positive selection in a densely sampled household cohort over three seasons
      Bendall EE, Zhu Y, Fitzsimmons WJ, Rolfes M, Mellis A, Halasa N, Martin ET, Grijalva CG, Talbot HK, Lauring AS. Virus Evolution, veae084 DOI:10.1093/ve/veae084
    • Journal Article
      HLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection.
      Olp MD, Laufer VA, Valesano AL, Zimmerman A, Woodside KJ, Lu Y, Lauring AS, Cusick MF. Life (Basel), 2024 Sep 19; 14 (9): DOI:10.3390/life14091181
      PMID: 39337964
    • Journal Article
      HLA-C peptide repertoires as predictors of clinical response during early SARS-CoV-2 infection
      Olp M, Laufer V, Valesano A, Zimmerman A, Woodside K, Najor M, Lu Y, Lauring A, Cusick M. Human Immunology, 2024 Sep; 85: 110860 DOI:10.1016/j.humimm.2024.110860
    • Journal Article
      Respiratory Viral Infections from 2015 to 2022 in the HIVE Cohort of American Households: Incidence, illness characteristics, and seasonality.
      Monto AS, Foster-Tucker JE, Callear AP, Leis AM, Godonou E-T, Smith M, Truscon R, Johnson E, Thomas LJ, Thompson MS, Fry AM, Flannery B, Malosh RE, Petrie JG, Lauring AS, Martin ET. J Infect Dis, 2024 Aug 24; DOI:10.1093/infdis/jiae423
      PMID: 39179953
    • Journal Article
      Influenza A virus within-host evolution and positive selection in a densely sampled household cohort over three seasons.
      Bendall EE, Zhu Y, Fitzsimmons WJ, Rolfes M, Mellis A, Halasa N, Martin ET, Grijalva CG, Talbot HK, Lauring AS. bioRxiv, 2024 Aug 19; DOI:10.1101/2024.08.15.608152
      PMID: 39229225
    • Preprint
      The impacts of viral interaction on household transmission of respiratory viruses
      Ibiebele JC, Godonou E-T, Callear AP, Smith MR, Truscon R, Johnson E, Eisenberg MC, Lauring AS, Monto AS, Cobey S, Martin ET. medRxiv, DOI:10.1101/2024.07.19.24310723
    • Preprint
      Surveillance of H5 HPAI in Michigan using retail milk
      Lauring A, Martin ET, Eisenberg M, Fitzsimmons W, Salzman E, Leis A, Lyon-Callo S, Bagdasarian N. 2024 bioRxiv, DOI:10.1101/2024.07.04.602115
    Featured News & Stories
    News Release
    Building a COMPASS to navigate future pandemics
    An $18 million National Science Foundation grant will establish a new center to bring computer science, infectious disease, engineering, and the arts together to predict and prevent global pandemics
         Microscopic rendering of the flu virus with green, purple and red coloring
    News Release
    $10 million NIH-award establishes new U-M center to study genomics of infectious disease pathogens
    A new NIH award will establish the Michigan Infectious Disease Genomics (MIDGE) Center, the goal of which is to use whole genome sequencing and functional genomic assays to determine how genetic differences among strains or isolates affect the behavior, transmission, and drug resistance of viral, bacterial, and fungal pathogens.
         Q&A with trainees at MMMP scientific symposium, June 18, 2024
    Department News
    MMMP celebrates 25 years of its NIH T32 training grant
    The Department of Microbiology and Immunology (M&I) celebrated 25 years of its NIH T32 training grant that supports the Molecular Mechanisms in Microbial Pathogenesis Training Program (MMMP) with a scientific symposium, held June 18, 2024.
         Lab of Erin M. Janssen, M.D., Ph.D.
    Medical School News
    Labs go platinum: Research teams record efforts to achieve sustainability certification
    Many Michigan Medicine labs are taking time to ensure that they are doing their part to support the Medical School’s major initiatives, including the push for carbon neutrality.